A hazard quotient approach for assessing the risk to non-target arthropods from

The EU Plant Protection Product Directive 91/414/EEC recommends the EPPO/CoE Arthropod Natural Enemies Risk Assessment Scheme for guidance on how to conduct risk assessments for terrestrial non-target arthropods. This scheme is currently in the process of being revised by EPPO/ CoE. A major change will be the recommendation for the generation and use of ’Dose Response’ toxicity data instead of limit test data. In addition, the revised EPPO/CoE Non-target Arthropods Risk Assessment Scheme will replace the current arbitrary 30% threshold trigger value applied to limit test data, with a Hazard Quotient (HQ; = Ratio Application Rate/LC50 on Glass)), comparable to the successful approach adopted in the EPPO/CoE ’Honeybee Risk Assessment Scheme’. However, in order for this new approach to be implemented under 91/414/EEC, an appropriate regulatory HQ trigger value needs to be derived. Such an HQ trigger value has been established by calculating HQ values for the 2 recommended sensitive indicator species (T pyri andAphidius) for a wide range of products and validating opposite robust semi-field/field data. This validation indicated that an HQ trigger value of ≥ 12 forT pyri and ≥ 8 forAphidius spp., should be used to trigger higher-tier risk assessment and/or higher-tier testing for non-target arthropods. As these trigger values were validated with realistic semi-field/ field data they apply for both lethal and sub-lethal effects as well as single and multiple application scenarios. Due to the worst case assumptions used in this HQ validation analysis, no further uncertainty factors need to be applied for in-crop risk assessment. Whilst a small amount of uncertainty exists regarding the comparative sensitivity ofT pyri andAphidius spp. for off-crop non-target arthropod guilds of arthropods, this is balanced by the fact that the off-crop exposure assessment used in the HQ derivation, is at least an order of magnitude higher than that realistically likely in the field. This HQ approach and trigger value is an appropriate and conservative tool for tier 1 risk assessment, which should reduce the number of false positive results leading to unnecessary higher-tier testing.     

Factors associated with the effectiveness of antibiotic treatment for ovine virulent footrot

Factors associated with the proportion of sheep cured of virulent footrot after antibiotic treatment were studied in a field trial under dry environmental conditions. From 2 similar flocks, 1091 Merino sheep weighing about 50 kg and infected with virulent footrot received an intramuscular injection of either 12 mL of a mixture of penicillin (250 mg/mL) and streptomycin (250 mg/mL), 6 mL of long acting oxytetracycline (200 mg/mL) or 6 mL of a mixture of lincomycin (50 mg/mL) and spectinomycin (100 mg/mL). Variables that were significantly associated with the proportion of sheep cured were: the type of antibiotic used, the number of feet infected and the flock from which the sheep came. There was an interaction between antibiotic type and number of feet infected and between antibiotic type and flock in association with the proportion of sheep cured. The extent of paring and the occurrence of blowfly strike in footrot lesions treated with diazinon had no significant association with the proportion of sheep cured.     

Some effects of limited exercise on purpose-bred beagles

Amendments to the Animal Welfare Act (PL 99-198) require that an exercise program for dogs be established by the attending veterinarian. A 6-week study was conducted to determine the effects of a moderate exercise program in purpose-bred Beagles. Sixteen male Beagles (4/group) were maintained as follows: (1) standard cage without exercise; (2) standard cage with individual exercise periods (35 minutes, 3 times/week); (3) large cage without exercise; and (4) standard cage with group-release exercise periods. Blood samples were collected for CBC, serum biochemical analysis including determination of serum cortisol concentration, and immune function (lymphocyte transformation assay). Group-released dogs interacted with each other during most of the exercise time. Fighting in these dogs occurred only during the third week. Dogs had little inclination to exercise when released alone into the exercise area. Regardless of the size of the cage, dogs did not exercise unless human beings were present in the room. There were no significant differences in laboratory findings among dogs in the 4 groups. This moderate exercise program had no demonstrable effects. Similarly, continuous cage housing, without a formal exercise program, could not be determined to be detrimental to the physiologic or health status of dogs.     

Effects of oral sunflower oil and olive oil on serum and cutaneous fatty acid concentrations in dogs.

The effects of dietary fatty acids on serum and cutaneous fatty acids of healthy dogs were evaluated under controlled conditions. Beagle puppies (n = 12) were fed a standard diet supplemented with sunflower oil (group A), olive oil (group B) or no supplementation (group C) for 12 weeks. There were no significant differences in food intake or growth rates between the three groups. Dogs in group A had significant increases (P < 0.05) in serum 18:2n6 (linoleic acid) and 20:3n6 (dihomo-gamma-linolenic acid), and cutaneous 18:2n6 with significant decreases in serum 20:4n6 (arachidonic acid) and cutaneous 18:1n9 (oleic acid) and 18:3n3 (alpha-linolenic acid). Dogs in group B had significant increases in serum 18:1n9, 20:3n6 and cutaneous 18:1n9 with decreases in serum 20:4n6, 22:4n6, 22:5n3 and 22:5n6, and cutaneous 18:2n6, 18:3n3 and 20:4n6. There were no significant changes in serum or cutaneous fatty acids for the dogs in group C. This study demonstrates that fatty acid supplements can be used to alter the serum and cutaneous fatty acid compositions of dogs.     

Growth performance and carcass composition of lambs infused for 28 days with a growth hormone-releasing factor analogue.

A human growth hormone-releasing factor analogue, [DesNH2Tyr1,D-Ala2,Ala15]hGRF(1-29)NH2 (GRF-A), was infused s.c. into lambs for 28 d to determine its effects on growth performance and carcass composition. Twenty crossbred wethers weighing 47.0 +/- .5 kg were implanted with 7-d osmotic minipumps at weekly intervals. Minipumps contained either vehicle (dimethyl sulfoxide:H2O, 1:1) or GRF-A, released at a rate of 208 pmol (or .7 micrograms).h-1.kg-1. During the infusion period, plasma GH levels were increased (P less than .01) in GRF-A-treated wethers compared with control wethers (15.0 vs 9.3 ng/ml) and were higher on days that closely followed minipump implantation. Plasma IGF-I and hepatic IGF-I RNA concentrations were similar in lambs of both groups. Analogue treatment improved feed conversion (4.9 vs 5.8 kg dry matter/kg gain, P less than .05), increased average daily gain (.35 vs .30 kg, P = .05) and had no effect on feed intake, wool growth and body, carcass, selected organ and pituitary weights. Carcasses from GRF-A-infused lambs had less adjusted fat depth, a lower percentage of fat and a higher percentage of protein (P less than .05) than carcasses from control lambs. Magnitude of most effects of GRF-A on carcass measurements were correlated with the mean GH level that a lamb had during the infusion period. In conclusion, s.c. infusion of GRF-A improved feed utilization and altered carcass composition of feeder lambs in a relatively short period of time (28 d).     

Interrelationships between energy intake and endogenous porcine growth hormone administration on the performance, body composition and protein and energy metabolism of growing pigs weighing 25 to 55 kilograms live weight

Thirty-six barrows were used in a 2 X 3 factorial experiment to investigate the effects of porcine growth hormone (pGH) administration (USDA-pGH-B1; 0 and 100 micrograms.kg body weight-1.d-1) and three levels of feeding of a single diet (EI; ad libitum, 1.64 and 1.38 kg/d) on the performance, body composition and rates of protein and fat deposition of pigs growing over the live weight phase 25 to 55 kg. Raising EI resulted in linear increases in growth rate and in protein and fat accretion but had no effect on the feed to gain ratio (F/G). Carcass fat content and carcass fat measurements also increased with EI, whereas carcass protein and water decreased (P less than .01). Growth hormone administration resulted in improvements in growth rate (16 to 26%), F/G (23%), protein deposition (34 to 50%) and increases in carcass protein and water at each level of feeding, but reduced ad libitum feed intake (P less than .01), carcass fat content (P less than .01) and carcass fat measurements (P less than .01). Estimated maintenance energy expenditure was increased by pGH administration (2.02 vs 1.72 Mcal digestible energy/d). Results indicate that the effects of pGH on growth performance and energy and protein metabolism were largely independent of, and additive to, the effects of energy intake.